# Monopar Therapeutics (MNPR) - Q4 2025 earnings

Reported March 27, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | - | Not available |
| EPS | $-0.61 | $-0.51 |

Earnings filing reader: [8-K 0001437749-26-010030](https://www.opencapital.sh/filings/0001437749-26-010030)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001437749-26-010030.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1645469/000143774926010030/0001437749-26-010030-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/0001437749-26-010025-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/mnpr/earnings/q4-2025